This is from the latest TXTM quarterly report:
The following table sets forth information regarding the beneficial ownership of our common stock with
respect to each of our executive officers, each of our directors, each person known by us to own beneficially
more than 5% of the common stock, and all of our directors and executive officers as a group as of June 30,
2017. Each individual or entity named has sole investment and voting power with respect to shares of
common stock indicated as beneficially owned by them, except where otherwise noted.
Plandaí Biotechnology, Inc.(1)
17 Hanover Square
London, England Series D Preferred 90,000 100%
Steve Berman(2) Series C Preferred 2,675,000 100%
Jay Safier(2) Series B Preferred 46,052 100%
Rock Island Capital(2)
Series A Preferred 10,000 13%
Richard Grossfeld(2) Series A Preferred 16,623 22%
David Lewis(2) Series A Preferred 49,500 65%
This is the Equity Shown in the latest Quarterly:
Equity
Common Stock, 10,000,000,000 shares par value $0.0001
authorized, 3,644,721,108 and 1,946,690,324 issued and
outstanding as of September 30, 2017 and December 31, 20
36,447 19,467
Common Stock Issuable 116,750 -
Additional Paid-in Capital 1,560,898 1,160,880
76 79
1 1
2,675 2,675
100 100
Retained Deficit (1,027,134) (538,300)
Total Equity 689,813 644,902
TOTAL LIABILITIES & EQUITY $ 2,603,784 $ 2,533,395
Preferred Stock-Series A 100,000 par value $0.001 shares
authorized, 76,123 shares issued and outstanding as of September
30, 2017 and December 31, 2016
Preferred Stock - Series C 9,000,000 par value $0.001 shares
authorized, 2,675,0000 issued and outstanding as of September
30, 2017 and December 31, 2016
Preferred Stock - Series D 100,000 par value $0.001 shares
authorized, 100,000 shares issued and outstanding as of
September 30, 2017 and December 31, 2016
Preferred Stock-Series B 1,000,000 par value $0.0001 shares
authorized, 504,003 shares issued and outstanding as of
September 30, 2017 December 31, 2016
PROTEXT MOBILITY, INC.
Balance Sheets as of
September 30, 2017 and December 31, 2016
(Unaudited)
Common Stock, 10,000,000,000 shares par value $0.0001
authorized, 3,644,721,108 and 1,946,690,324 issued and
outstanding as of September 30, 2017 and December 31, 2016
The following table sets forth information regarding the beneficial ownership of our common stock with
respect to each of our executive officers, each of our directors, each person known by us to own beneficially
more than 5% of the common stock, and all of our directors and executive officers as a group as of June 30,
2017. Each individual or entity named has sole investment and voting power with respect to shares of
common stock indicated as beneficially owned by them, except where otherwise noted.
Plandaí Biotechnology, Inc.(1)
17 Hanover Square
London, England Series D Preferred 90,000 100%
Steve Berman(2) Series C Preferred 2,675,000 100%
Jay Safier(2) Series B Preferred 46,052 100%
Rock Island Capital(2)
Series A Preferred 10,000 13%
Richard Grossfeld(2) Series A Preferred 16,623 22%
David Lewis(2) Series A Preferred 49,500 65%
This is the Equity Shown in the latest Quarterly:
Equity
Common Stock, 10,000,000,000 shares par value $0.0001
authorized, 3,644,721,108 and 1,946,690,324 issued and
outstanding as of September 30, 2017 and December 31, 20
36,447 19,467
Common Stock Issuable 116,750 -
Additional Paid-in Capital 1,560,898 1,160,880
76 79
1 1
2,675 2,675
100 100
Retained Deficit (1,027,134) (538,300)
Total Equity 689,813 644,902
TOTAL LIABILITIES & EQUITY $ 2,603,784 $ 2,533,395
Preferred Stock-Series A 100,000 par value $0.001 shares
authorized, 76,123 shares issued and outstanding as of September
30, 2017 and December 31, 2016
Preferred Stock - Series C 9,000,000 par value $0.001 shares
authorized, 2,675,0000 issued and outstanding as of September
30, 2017 and December 31, 2016
Preferred Stock - Series D 100,000 par value $0.001 shares
authorized, 100,000 shares issued and outstanding as of
September 30, 2017 and December 31, 2016
Preferred Stock-Series B 1,000,000 par value $0.0001 shares
authorized, 504,003 shares issued and outstanding as of
September 30, 2017 December 31, 2016
PROTEXT MOBILITY, INC.
Balance Sheets as of
September 30, 2017 and December 31, 2016
(Unaudited)
Common Stock, 10,000,000,000 shares par value $0.0001
authorized, 3,644,721,108 and 1,946,690,324 issued and
outstanding as of September 30, 2017 and December 31, 2016
On4 Communications (ONCI) Stock Research Links
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'
https://twitter.com/twitter/statuses/957208055766241280
https://twitter.com/twitter/statuses/957208055766241280
